- Home
- Publications
- Publication Search
- Publication Details
Title
Disruptive Technology: CRISPR/Cas-Based Tools and Approaches
Authors
Keywords
-
Journal
Molecular Diagnosis & Therapy
Volume 23, Issue 2, Pages 187-200
Publisher
Springer Nature
Online
2019-04-04
DOI
10.1007/s40291-019-00391-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gene Therapy for Beta-Hemoglobinopathies: Milestones, New Therapies and Challenges
- (2019) Valentina Ghiaccio et al. Molecular Diagnosis & Therapy
- Rare Opportunities: CRISPR/Cas-Based Therapy Development for Rare Genetic Diseases
- (2019) Panayiota Papasavva et al. Molecular Diagnosis & Therapy
- Base editing with a Cpf1–cytidine deaminase fusion
- (2018) Xiaosa Li et al. NATURE BIOTECHNOLOGY
- CRISPOR: intuitive guide selection for CRISPR/Cas9 genome editing experiments and screens
- (2018) Jean-Paul Concordet et al. NUCLEIC ACIDS RESEARCH
- A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing
- (2018) Jonathan D. Finn et al. Cell Reports
- Evolved Cas9 variants with broad PAM compatibility and high DNA specificity
- (2018) Johnny H. Hu et al. NATURE
- CRISPR-Mediated Base Editing Enables Efficient Disruption of Eukaryotic Genes through Induction of STOP Codons
- (2017) Pierre Billon et al. MOLECULAR CELL
- CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo
- (2017) Lei Xu et al. MOLECULAR THERAPY
- Engineered Cpf1 variants with altered PAM specificities
- (2017) Linyi Gao et al. NATURE BIOTECHNOLOGY
- Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9
- (2017) Jiangtao Ren et al. Protein & Cell
- Lineage-specific BCL11A knockdown circumvents toxicities and reverses sickle phenotype
- (2016) Christian Brendel et al. JOURNAL OF CLINICAL INVESTIGATION
- CRISPR-Mediated Base Editing without DNA Double-Strand Breaks
- (2016) Brian S. Plosky MOLECULAR CELL
- Genome-editing Technologies for Gene and Cell Therapy
- (2016) Morgan L Maeder et al. MOLECULAR THERAPY
- Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells
- (2016) Benjamin P Kleinstiver et al. NATURE BIOTECHNOLOGY
- RS-1 enhances CRISPR/Cas9- and TALEN-mediated knock-in efficiency
- (2016) Jun Song et al. Nature Communications
- Post-translational Regulation of Cas9 during G1 Enhances Homology-Directed Repair
- (2016) Tony Gutschner et al. Cell Reports
- Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing
- (2016) Rafal Kaminski et al. Scientific Reports
- A Genome-wide CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Screen Identifies NEK7 as an Essential Component of NLRP3 Inflammasome Activation
- (2015) Jonathan L. Schmid-Burgk et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Engineered CRISPR-Cas9 nucleases with altered PAM specificities
- (2015) Benjamin P. Kleinstiver et al. NATURE
- Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
- (2014) Luke A. Gilbert et al. CELL
- Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing
- (2014) Shengdar Q Tsai et al. NATURE BIOTECHNOLOGY
- Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery
- (2014) Steven Lin et al. eLife
- Targeting Hepatitis B Virus With CRISPR/Cas9
- (2014) Christoph Seeger et al. Molecular Therapy-Nucleic Acids
- CRISPR interference (CRISPRi) for sequence-specific control of gene expression
- (2013) Matthew H Larson et al. Nature Protocols
- DNA double-strand-break complexity levels and their possible contributions to the probability for error-prone processing and repair pathway choice
- (2013) A. Schipler et al. NUCLEIC ACIDS RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started